Hello,

We are working on refolding HLA A2 in the presence of a known HLA A2-binding peptide. Our alpha chain is about 80% pure and our B2m is >90% pure. After rapid dilution in the refolding buffer, and allowing the solution to incubate for 48 hrs, we concentrate our protein using a biomax 10 kDa membrane connected to a peristaltic pump. We then inject our solution into an FPLC and observe 2 peaks, one for the aggregate and one soluble peak. SDS page gels reveal that the aggregate is mostly the alpha chain (some of which is dimerized) and the soluble peak is only the B2 domain. Has anyone experienced a similar problem, and how should we address this? We are suspicious of our peptide, but want to consider other explanations for our results.

We use the following protocol for refolding:

https://www.nki.nl/media/598229/Generation%20of%20peptide%20MHC%20class%20I%20monomers%20and%20multimers%20through%20ligand%20exchange.pdf

Similar questions and discussions